Savaria (TSE:SIS) Given New C$35.00 Price Target at Desjardins

Savaria (TSE:SIS) had its price objective upped by Desjardins from C$32.00 to C$35.00 in a report released on Thursday morning,BayStreet.CA reports. Desjardins currently has a buy rating on the stock.

A number of other analysts have also commented on SIS. TD increased their price objective on Savaria from C$31.00 to C$35.00 and gave the company a “buy” rating in a research note on Wednesday. ATB Cormark Capital Markets increased their price objective on Savaria from C$32.00 to C$35.00 and gave the company an “outperform” rating in a research note on Wednesday. Raymond James Financial increased their price objective on Savaria from C$32.00 to C$33.00 and gave the company an “outperform” rating in a research note on Wednesday. TD Securities increased their price objective on Savaria from C$27.00 to C$31.00 and gave the company a “buy” rating in a research note on Thursday, March 5th. Finally, Scotiabank increased their price objective on Savaria from C$29.00 to C$30.00 and gave the company an “outperform” rating in a research note on Friday, March 6th. Nine research analysts have rated the stock with a Buy rating, According to MarketBeat, Savaria currently has an average rating of “Buy” and an average price target of C$32.61.

Savaria Stock Down 0.7%

SIS opened at C$28.59 on Thursday. The company has a quick ratio of 0.91, a current ratio of 1.61 and a debt-to-equity ratio of 32.13. The firm has a market cap of C$2.06 billion, a P/E ratio of 29.78, a PEG ratio of 42.72 and a beta of 0.86. Savaria has a 52 week low of C$16.13 and a 52 week high of C$30.41. The business’s fifty day simple moving average is C$26.16 and its 200 day simple moving average is C$23.74.

Savaria (TSE:SIS) last posted its quarterly earnings data on Wednesday, March 4th. The company reported C$0.37 EPS for the quarter. The business had revenue of C$241.78 million for the quarter. Savaria had a return on equity of 11.10% and a net margin of 7.53%. As a group, equities research analysts anticipate that Savaria will post 1.2048518 EPS for the current fiscal year.

Insider Transactions at Savaria

In other Savaria news, insider Jean-Philippe De Montigny purchased 2,420 shares of the firm’s stock in a transaction on Friday, March 20th. The shares were purchased at an average cost of C$25.50 per share, with a total value of C$61,710.00. Following the purchase, the insider owned 92,260 shares in the company, valued at approximately C$2,352,630. This represents a 2.69% increase in their ownership of the stock. Insiders own 17.45% of the company’s stock.

Savaria News Roundup

Here are the key news stories impacting Savaria this week:

• Positive Sentiment: Desjardins raised its price target to C$35.00 and kept a “buy” rating — about a 22.8% upside from current levels. BayStreet.CA
• Positive Sentiment: Scotia raised its target to C$33.00 and set a “sector outperform” rating — ~15.7% implied upside. BayStreet.CA
• Positive Sentiment: ATB Cormark Capital Markets bumped its target to C$35.00 and kept an “outperform” call — ~21.6% upside. BayStreet.CA
• Positive Sentiment: Raymond James raised its target to C$33.00 and maintained an “outperform” rating — ~14.7% implied upside. BayStreet.CA
• Positive Sentiment: TD increased its target to C$35.00 and kept a “buy” rating — ~21.6% upside; coverage also noted on TickerReport. BayStreet.CA TickerReport

Savaria Company Profile

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.